U.S. stocks are little changed early Wednesday, one day after a strong rally sent to the S&P 500 to a…
Ozempic maker Novo Nordisk and Mounjaro maker Eli Lilly dominate the lucrative weight loss drug market with Wegovy and Zepbound,…
Amazon Pharmacy second online pharmacy to partner with Eli Lillys site, and could provide faster deliveries for certain patients.…
"Bloomberg Markets" follows the market moves across every global asset class and discusses the biggest issues for Wall Street. Guests…
…
A relatively tiny company ($508 million market cap) that most investors have never heard of has been doling out a…
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…
Here are Mondays biggest calls on Wall Street.…
…
The FDA decision on Eli Lillys (LLY) Alzheimers candidate, donanemab, was expected in the first quarter of 2024, which has…
Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.…
…
Good news could be in store for all three of these drugmakers.…
…
Lillys recently approved weight-loss drug is off to a good start.…
These are the stocks posting the largest moves in midday trading.…
The FDA decision delay is surprising and disappointing, Jim Cramer said Friday. But its not a thesis-shattering event.…
The FDA plans to call a last-minute meeting of its outside advisors to further review the Eli Lilly Alzheimers treatments…
INDIANAPOLS (dpa-AFX) - Der US-Arzneimittelhersteller Lilly muss womöglich noch länger auf eine Zulassung seines Alzheimermittels…
FDA to review Eli Lillys Alzheimers drug donanemab…
Cignas Evernorth struck agreements with Novo Nordisk and Eli Lilly to limit spending increases for those GLP-1s to a maximum…
Novo Nordisk shares climbed 5% on Thursday morning after the Danish pharmaceutical giant reported positive early trial data for a…
Eli Lilly and Novo Nordisk dominate the diabetes market thanks to blockbuster medications Mounjaro, Ozempic, and Rybelsus.…
…
One is a reigning champion, and the other is a burgeoning contender.…
CNBCs Jim Cramer named Nvidia, Eli Lilly and Novo Nordisk as companies that deserve high valuations.…
Anyone doubting the stock market rally has legs should just have a short conversation with Ken Fisher. The billionaire investor…
Here are Mondays biggest calls on Wall Street.…
There are two big reasons why Eli Lilly stock is as much as 5x more expensive than Pfizer.…
The tricky part would have been to not sell the pharmaceutical giants shares when Soros did.…
The tricky part would have been to not sell the pharmaceutical giants shares when Soros did.…
This is a close contest, and itll go on for at least a few more rounds.…
…
These two biotechs could eventually go head to head in a fast-growing market.…
Eli Lilly stock is having a moment, but the company could easily continue soaring.…
…
Bank of America analysts raise Eli Lilly price target amid obesity drug optimism…
Here are Fridays biggest calls on Wall Street.…
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
Viking Therapeutics’ stock more than doubled on Tuesday following the release of trials results suggesting its injectable obesity treatment outperforms…
Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but its coming.…
Zealand Pharma, Eli Lilly show the potential of treating liver disease with weight loss drugs, while the Change Healthcare outage…
A pharma giant and a gas stock were in focus among early analyst calls on Tuesday.…
Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter &…
CNBCs Jim Cramer on Monday said Eli Lilly, Berkshire Hathaway, Tesla and Broadcom have a chance to break the $1…
Zealand Pharmas Phase 2 trial was an "uniquivocal win" for a drug that can treat both liver disease and obesity,…
Why would Eli Lilly put on a failure party?…
…
Shares of Eli Lilly have risen by roughly 1,190% over the past 10 years.…
Eli Lilly is home to many blockbuster drugs including Mounjaro, Jardiance, Zepbound, and more.…